CompletedNot applicableNCT02923206

Proof-of-Concept Trial on Selective Removal of sFlt-1 in Pregnant Women With Preeclampsia Via Apheresis

Studying Preeclampsia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Miltenyi Biomedicine GmbH
Principal Investigator
Thomas Benzing, Prof. Dr.
University Clinic Cologne
Intervention
TheraSorb sFlt-1 adsorber(device)
Enrollment
21 target
Eligibility
18-45 years · All sexes
Timeline
20162025

Study locations (4)

Collaborators

Cromsource

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02923206 on ClinicalTrials.gov

Other trials for Preeclampsia

Additional recruiting or active studies for the same condition.

See all trials for Preeclampsia

← Back to all trials